HOME >> MEDICINE >> NEWS
Policy-makers should enhance selection process for Presidential S&T appointments

give high-ranking leaders in science and technology earlier opportunities to contribute to relevant policy discussions, the report says. Efforts to streamline could include conducting one background check rather than separate reviews by the White House and Senate, clarifying job criteria, and simplifying financial disclosure rules. Conflict-of-interest requirements also should be reviewed to ensure that they are neither too burdensome nor too lenient.

APPOINTMENTS TO FEDERAL ADVISORY COMMITTEES

Many scientists, engineers, and health professionals serve on roughly 1,000 federal S&T advisory committees, examining issues such as safety standards for drinking water and biodefense priorities. Some are chosen for their policy expertise, but most are selected for their scientific and technical knowledge. Experts who are nominated mainly to provide scientific or technical advice in particular fields should be chosen for their credentials and integrity -- not for irrelevant criteria, the report says. Also, conflict-of-interest requirements should not be so burdensome that top scientists, engineers, and health professionals are unwilling to serve on advisory committees particularly committees that review research proposals or provide direction to federal research programs.

The S&T perspectives of advisory committee candidates and their possible biases should be disclosed and discussed in closed sessions with committee members and department or agency staff at a committee's initial meeting. Doing so would provide context and help officials determine whether they need to appoint more committee members to balance strong opinions, as required by federal law.

Overall, heads of departments or agencies should establish a more visible process for nominating and appointing people, the report says. And the process should be supported by explicit policies and procedures. Staff members should be held accountable for its implementat
'"/>

Contact: Vanee Vines
NEWS@NAS.EDU
202-334-2138
The National Academies
18-Nov-2004


Page: 1 2 3 4

Related medicine news :

1. HIV testing should be routine part of primary health care for sexually active
2. Opponents of needle-exchange programs should think about their message to drug users
3. Public policy should address the social factors behind ill health
4. Ethical discussion should come before research
5. Age shouldnt be a factor in kidney transplantation
6. Pregnant women should exercise to keep depression away
7. HIV testing should no longer be accorded any special status
8. Branding practices in rural India should be banned
9. Diagnosis of prions in patients should utilize novel strategy, team says
10. How often should women get mammograms?
11. Women should be advised not to drink alcohol in pregnancy

Post Your Comments:
(Date:6/19/2013)... The former internist for the St. Louis ... serves as director of prevention and wellness at St. ... personal encounter with a metabolic syndrome diagnosis and a ... , that he credits with sparking the paradigm-shift that ... practice. , “The average medical student gets 30 minutes ...
(Date:6/19/2013)... Recently, SoCal CEO Magazine staff was on hand ... in a series of six workshops where people with and without ... the mosaic tiles in their permanent location under the direction of ... Maxwell. , This mural project began in March of 2013 ... three years ago with the goal of promoting ...
(Date:6/19/2013)... The US Food and Drug Administration (FDA) announced ... breast implant, Mentor Worldwide’s MemoryShape™. , The FDA approved Sientra/Silimed ... FDA announced the approval of the MemoryShape™ implant on June ... in women 22 years old or older and in ... FDA’s approval comes after six years of data from 955 ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
(Date:6/19/2013)... fact that the incidence of cancer is many fold ... still have an inadequate understanding on how best to ... patients are occasionally included in clinical trials, those elderly ... elderly patients. Thus, the broader elderly patient population is ... in the Elderly Task Force is now starting a ...
Breaking Medicine News(10 mins):Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
(Date:6/19/2013)... 19. Juni 2013 Specialty ... der Entwicklung von SCS microRESIST™, einer ... der Beschichtung mit Parylene gelungen ist. ... biokompatiblem Parylene mit antimikrobiellen Eigenschaften und ... Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: